• Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Viewpoint
    Aug. 28, 2023

    In today’s business environment, life sciences enterprises face a significant challenge: negotiating and securing favorable global contracts to meet projected revenue and profit targets. This challenge initiates a complex revenue transaction process involving multiple entities within…